ErbB4 antagonists
    2.
    发明申请
    ErbB4 antagonists 审中-公开
    ErbB4拮抗剂

    公开(公告)号:US20070092513A1

    公开(公告)日:2007-04-26

    申请号:US11581221

    申请日:2006-10-13

    IPC分类号: A61K39/395

    摘要: The present invention concerns methods and means for controlling excessive proliferation and/or migration of smooth muscle cells, and in particular for treating stenosis, by using antagonists of a native ErbB4 receptor. The invention further concerns a method for the identification of ErbB4 agonists and antagonists capable of inhibiting or enhancing the proliferation or migration of smooth muscle cells.

    摘要翻译: 本发明涉及通过使用天然ErbB4受体的拮抗剂来控制平滑肌细胞的过度增殖和/或迁移,特别是用于治疗狭窄的方法和手段。 本发明还涉及鉴定能够抑制或增强平滑肌细胞增殖或迁移的ErbB4激动剂和拮抗剂的方法。

    METHODS FOR THE TREATMENT OF CARCINOMA
    10.
    发明申请

    公开(公告)号:US20070141068A1

    公开(公告)日:2007-06-21

    申请号:US11671987

    申请日:2007-02-06

    IPC分类号: A61K39/395 C07K16/30

    摘要: The invention concerns compositions and methods for the diagnosis and treatment of neoplastic cell growth and proliferation in mammals, including humans. The invention is based upon the identification of genes that are amplified in the genome of tumor cells, such as renal cell carcinoma. Such gene amplification is expected to be associated with the overexpression of the gene product as compared to normal cells of the same tissue type and contribute to tumorigenesis. Accordingly, the proteins encoded by the amplified genes are believed to be useful targets for the diagnosis and/or treatment (including prevention) of certain cancers, such as renal cell carcinoma, and may act as predictors of the prognosis of tumor treatment. The present invention is directed to novel methods of diagnosing and treating tumor, such as renal cell carcinoma or Wilms tumor.